KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,467,812 | +462.5% | 55,757 | +469.2% | 0.01% | +600.0% |
| Q2 2023 | $1,149,933 | +156.7% | 9,795 | +75.1% | 0.00% | – |
| Q1 2023 | $447,936 | -11.7% | 5,595 | -12.6% | 0.00% | -100.0% |
| Q4 2022 | $507,008 | -10.3% | 6,400 | -21.0% | 0.00% | 0.0% |
| Q3 2022 | $565,000 | +6.2% | 8,100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $532,000 | +110.3% | 8,100 | +112.7% | 0.00% | – |
| Q1 2022 | $253,000 | -64.3% | 3,809 | -71.9% | 0.00% | -100.0% |
| Q3 2021 | $709,000 | +44.1% | 13,571 | +87.4% | 0.00% | – |
| Q2 2021 | $492,000 | – | 7,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |